Agios Pharmaceuticals, Inc.
AGIO
$27.42
-$0.07-0.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -401.27M | 650.08M | 665.99M | 673.73M | 674.31M |
| Total Depreciation and Amortization | 5.28M | 5.25M | 5.58M | 5.65M | 5.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.77M | -1.03B | -1.05B | -1.05B | -1.04B |
| Change in Net Operating Assets | -74.71M | -29.13M | -27.29M | -19.77M | 32.09M |
| Cash from Operations | -409.93M | -406.00M | -401.46M | -389.84M | -329.16M |
| Capital Expenditure | -4.16M | -3.03M | -2.31M | -1.69M | -952.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 40.00K | 40.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 200.00M | 200.00M | 200.00M | 200.00M |
| Other Investing Activities | 242.11M | 196.22M | 153.78M | 165.09M | 309.02M |
| Cash from Investing | 237.95M | 393.19M | 351.47M | 363.44M | 508.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.96M | 9.16M | 10.20M | 14.44M | 10.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.96M | 9.16M | 10.20M | 14.44M | 10.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.02M | -3.65M | -39.80M | -11.96M | 189.40M |